FundaMental Pharma raises €10.0M Seed round

17 November 2022· Heidelberg, Germany· health, neuroscience, biotech, b2b, deep_hardware

To advance first-in-class small molecule inhibitors for the treatment of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Huntington's Disease.

Investors

LeadBioGeneration Ventures

Also participating

High-Tech GründerfondsCoparionThuja Capital

About FundaMental Pharma

Stage

Seed

Headquarters

Heidelberg, Germany

Founded

2016

Team Size

6–20

Sectors

healthneurosciencebiotechb2bdeep_hardware

https://www.fundamentalpharma.com/

Source: https://www.globenewswire.com/news-release/2022/11/17/2557922/0/en/FundaMental-Pharma-launches-with-EUR-10-million-in-Seed-financing-led-by-BGV-and-Thuja-Capital-to-advance-a-First-in-Class-neuroprotectant.html